Prostate cancer is one of the most common types of cancer in men, originating in the prostate gland — a small, walnut-sized gland that produces seminal fluid. This type of cancer typically grows slowly and is confined to the prostate initially, where it may not cause significant harm. However, some forms of prostate cancer are aggressive and can spread quickly to other parts of the body, making early detection and understanding of potential causes crucial for prevention and treatment.
Related article: What Causes Cancer?
Table of Contents
Call 866-535-9515 or submit your case for review today!
Potential Causes of Prostate Cancer
The exact cause of prostate cancer is not fully understood, but certain risk factors have been identified that may increase the likelihood of developing the disease. These factors include:
- Age: The risk of prostate cancer increases significantly as men get older, with most cases diagnosed in men over 50.
- Race: African American men have a higher risk of prostate cancer compared to men of other races.
- Family history: Men with a father or brother who had prostate cancer are at an increased risk.
- Genetics: Certain inherited gene mutations, such as BRCA1 and BRCA2, can increase the risk of prostate cancer.
- Diet: A diet high in red meat and high-fat dairy products may increase the risk, while a diet rich in fruits and vegetables may lower it.
- Obesity: Being overweight or obese is associated with an increased risk of aggressive prostate cancer.
Emerging Concerns: Drugs and Consumer Products Linked to Prostate Cancer
While these factors are well-established, recent research has uncovered potential links between prostate cancer and certain environmental exposures and medications. Some of these emerging concerns include exposure to NDMA in certain drugs, AFFF (firefighting foam), and contaminated water at military bases like Camp Lejeune.
NDMA in Zantac and Prostate Cancer
Zantac, a popular heartburn medication, was found to contain NDMA, a potent carcinogen. NDMA is an environmental contaminant often found in water and foods, but in Zantac, it was present at levels far exceeding safe limits.
Studies suggest that prolonged exposure to NDMA can damage DNA and increase cancer risk, including prostate cancer. This discovery led to Zantac being recalled from the market and sparked numerous Zantac lawsuits from individuals who developed cancer after taking the medication.
Zantac users who were exposed to NDMA over time faced a higher risk of developing various cancers, including prostate cancer, due to the drug’s ability to alter the genetic makeup of cells. Lawyers representing affected individuals have argued that the manufacturers of Zantac failed to warn consumers about the cancer risks associated with NDMA exposure, resulting in serious health consequences for many.
NDMA in Valsartan and Prostate Cancer Risk
Similar to Zantac, Valsartan, a medication commonly prescribed for high blood pressure and heart failure, was also found to contain NDMA. The contamination was traced back to manufacturing issues, particularly in overseas facilities where certain chemical processes used in production led to the formation of NDMA.
This discovery led to a series of recalls and Valsartan lawsuits as affected patients sought compensation for their increased cancer risk.
NDMA contamination in Valsartan is particularly concerning because individuals taking the drug were often on long-term treatment regimens, leading to prolonged exposure. The carcinogenic effects of NDMA in Valsartan, much like in Zantac, include DNA damage that can contribute to the development of cancers such as prostate cancer.
AFFF Exposure and Prostate Cancer
Military and civilian firefighters have widely used Aqueous Film-Forming Foam (AFFF) for decades to suppress fuel fires. Unfortunately, AFFF contains per- and polyfluoroalkyl substances (PFAS), known as “forever chemicals” because they do not break down in the environment or the human body. PFAS exposure has been linked to various health problems, including an increased risk of prostate cancer.
Firefighters and military personnel who were regularly exposed to AFFF are at particular risk, as PFAS can accumulate in the body over time, leading to chronic health conditions. AFFF lawsuits have been filed against manufacturers of AFFF, alleging that they knowingly produced and sold products containing dangerous chemicals without adequately warning users of the risks. These lawsuits seek to hold manufacturers accountable for the health impacts of PFAS exposure, including its role in causing prostate cancer.
Camp Lejeune Water Contamination and Prostate Cancer
Between the 1950s and 1980s, military personnel, their families, and civilian workers at Marine Corps Base Camp Lejeune in North Carolina were exposed to highly contaminated drinking water. The water was tainted with various toxic chemicals, including trichloroethylene (TCE), perchloroethylene (PCE), benzene, and vinyl chloride. These substances are known to cause several types of cancer, including prostate cancer.
Those who lived or worked at Camp Lejeune during this time have reported higher incidences of cancer and other serious health conditions, prompting Camp Lejeune lawsuits against the government for failing to provide safe drinking water.
The contaminated water at Camp Lejeune has been linked to numerous health issues, and ongoing litigation seeks to compensate those affected, particularly for cancers that developed as a result of exposure.
The Path to Justice for Victims of Dangerous Drugs and Toxic Exposures
Prostate cancer is a complex disease with various potential causes, including age, genetics, and lifestyle factors. However, exposure to dangerous chemicals found in medications, firefighting foam, and contaminated water has raised significant concerns about preventable cancer risks.
NDMA in Zantac and Valsartan, PFAS in AFFF, and toxic substances in Camp Lejeune’s water supply have all been linked to an increased risk of prostate cancer, highlighting the need for accountability and legal recourse for affected individuals.
If you or a loved one has been diagnosed with prostate cancer and believe it may be linked to exposure to harmful chemicals or medications, it’s important to understand your legal rights. Consulting with an experienced attorney can help you determine if you have a case and guide you through the process of seeking compensation.
The attorneys at Lawsuit Legal News are committed to seeking justice for victims of dangerous drugs and toxic exposures. Contact us today at 866-535-9515 or complete our simple online form for a free consultation to discuss your case and legal options.